当前位置:首页 > 股票大全 > 颖泰生物 833819 财务分析

颖泰生物财务分析

整理编辑：168股票行情网：www.gphq168.com    数据来源：互联网 经供参考

颖泰生物(833819)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入1,374,078,857.915,868,305,351.834,395,196,061.072,954,829,186.08
营业总成本1,400,108,915.885,646,981,763.184,223,675,945.882,781,739,616.93
营业利润-24,851,116.44166,736,471.62215,064,701.42195,427,114.34
利润总额-25,379,276.19163,218,749.67212,489,136.36194,154,298.25
净利润-31,362,520.1291,174,238.94146,099,771.33146,539,635.29
其他综合收益-8,113,453.119,036,007.5359,895,948.1488,277,328.27
综合收益总额-39,475,973.22110,210,246.47205,995,719.47234,816,963.56
颖泰生物(833819)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计5,012,768,350.384,842,717,364.145,227,014,5925,556,019,134.03
非流动资产合计7,788,576,813.917,799,426,653.37,478,763,433.627,213,961,196.85
资产总计12,801,345,164.2912,642,144,017.4412,705,778,025.6212,769,980,330.88
流动负债合计6,045,432,625.65,933,423,754.045,952,509,627.236,143,504,547.99
非流动负债合计1,005,598,541.41920,181,127.15855,771,202.82578,508,232.19
负债合计7,051,031,167.016,853,604,881.196,808,280,830.056,722,012,780.18
归属于母公司股东权益合计5,748,612,855.835,785,267,304.65,892,113,359.566,038,712,428.72
股东权益合计5,750,313,997.285,788,539,136.255,897,497,195.576,047,967,550.7
负债和股东权益合计12,801,345,164.2912,642,144,017.4412,705,778,025.6212,769,980,330.88
颖泰生物(833819)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计812,069,678.245,349,414,459.494,156,720,102.992,791,862,556.23
经营活动现金流出小计971,377,508.065,311,187,408.264,220,928,401.93,081,281,900.19
经营活动产生的现金流量净额-159,307,829.8238,227,051.23-64,208,298.91-289,419,343.96
投资活动现金流入小计33,348,416575,955,633.16484,208,833.32427,203,110.32
投资活动现金流出小计198,590,304.511,104,275,653.28564,007,847.28386,623,752.14
投资活动产生的现金流量净额-165,241,888.51-528,320,020.12-79,799,013.9640,579,358.18
筹资活动现金流入小计1,368,193,792.624,887,575,472.243,965,761,552.792,171,746,942.64
筹资活动现金流出小计879,622,212.094,879,448,508.593,766,211,962.31,914,976,698.34
筹资活动产生的现金流量净额488,571,580.538,126,963.65199,549,590.49256,770,244.3
汇率变动对现金及现金等价物的影响5,363,137.99-398,919.84-366,752.53-1,190,157.32
现金及现金等价物净增加额169,385,000.19-482,364,925.0855,175,525.096,740,101.2
期末现金及现金等价物余额877,420,594.35708,035,594.161,245,576,044.331,197,140,620.44
颖泰生物833819相关数据
今日股市大盘指数